NCT05346809 2025-06-08Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaColumbia UniversityPhase 2 Recruiting39 enrolled
NCT06119685 2025-06-03IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersIndapta Therapeutics, INC.Phase 1/2 Recruiting128 enrolled